to purchase 5.0% of the aggregate number of shares of common stock sold in this offering at an exercise price equal to 120% of
China, through which we sell directly to individual customers traditional Chinese medicinal products produced by us as well as
comprises the following Chinese companies participating in our yew tree business: Shineco Zhisheng (Beijing) Bio-Technology Co.
acquired all of the issued and outstanding shares of Tenet-Jove, a company operating in the fabrics and textile business organized
from this offering to fund our PRC subsidiaries only through loans or capital contributions, subject to applicable government
direct investments in, PRC entities by offshore holding companies may delay or prevent us from using proceeds from this offering
are a holding company incorporated in Delaware, but we operate our businesses through our PRC subsidiaries and through various
public offering price are the future prospects of our company and our industry in general, our sales, earnings and certain other
disruption or natural disaster could severely disrupt our business and operations and significantly decrease our revenue and profitability.The retail price of some of our pharmaceutical products
price reductions may have a material adverse effect on our financial condition and results of operations, including significantly
of Chinese medicine, which is subject to various PRC laws and regulations pertaining to the pharmaceutical industry.
in China with a uniform law and, if adopted, could affect a wide range of foreign entities, including our Company, and investments
and accounting advisers to develop strategies to minimize the impact potential changes to existing Chinese laws regulating foreign
or accidents or business interruption, our results of operations could be materially and adversely affected.We are an “emerging growth company,” and
we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock
and adversely affect our business, brand and reputation and results of operations.We also expect that being a public company
on our business, financial condition, results of operations and prospects.Labor laws in the PRC may adversely affect our results
PRC subsidiaries and variable interests entities are generally subject to laws and regulations applicable to foreign investments
affect a wide range of foreign entities, including our Company, and investments generally in China.PRC regulation of loans and direct investment
equity securities in China, which may adversely affect our liquidity and our ability to fund and expand our business in the PRC.We may also decide to finance our subsidiaries
Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions,
and outstanding shares of Tenet-Jove, a company organized under the laws of the People’s Republic of China on December 15,
market, to medical materials company, such as Qianhe Pharmaceutical Industry Co. and to Chinese patent medicine factories, such
enhances our competitive position in the Chinese market for high quality textile products with perceived health benefits.44Chinese Laws and RegulationsLaws and Regulations in China Regarding Agriculture
could materially adversely affect our business, financial condition and results of operations.Pharmaceutical Administration Law of The People’s
People’s Republic of China and effective on June 1, 2009, governs the food safety in food production and business operation
is subject to a series of laws and regulations generally applicable to any foreign-invested enterprise in China, which include